🇺🇸 FDA
Company

Corbus

Corbus Pharmaceuticals Holdings

CRBP pharma USA

Quick answer

Corbus is a pharma company (CRBP) headquartered in NORWOOD, MA, USA with 10 tracked pipeline programs.

Pipeline (10)

project

Lenabasum 20 mg

Dermatomyositis

Phase 3 · small_molecule · completed

1 trials project

Lenabasum 5 mg

Diffuse Cutaneous Systemic Sclerosis

Phase 3 · small_molecule · terminated

1 trials project

CRB-601 monoclonal antibody

Solid Tumor

Phase 2 · small_molecule · active

1 trials project

CRB-701

Solid Tumor, Adult

Phase 2 · small_molecule · active

1 trials project

JBT-101

Diffuse Cutaneous Systemic Sclerosis

Phase 2 · small_molecule · terminated

1 trials project

JBT-101

Dermatomyositis

Phase 2 · small_molecule · terminated

1 trials project

JBT-101

Systemic Lupus Erythematosus

Phase 2 · small_molecule · completed

1 trials project

JBT-101 (lenabasum)

Cystic Fibrosis

Phase 2 · small_molecule · completed

1 trials project

Lenabasum 20 mg

Cystic Fibrosis

Phase 2 · small_molecule · completed

1 trials project

CRB-913

Obese But Otherwise Healthy Participants

Phase 1 · small_molecule · active

1 trials

Patents (6)

patent

US 11052066

Ultrapure tetrahydrocannabinol-11-oic acids

Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10369131

Ultrapure tetrahydrocannabinol-11-oic acids

Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10154986

Ultrapure tetrahydrocannabinol-11-oic acids

Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10085964

Ultrapure tetrahydrocannabinol-11-oic acids

Expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9820964

Ultrapure tetrahydrocannabinol-11-oic acids

Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9801849

Ultrapure tetrahydrocannabinol-11-oic acids

Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)